Dr. Mercola's Censored Library (Private Membership)

Dr. Mercola's Censored Library (Private Membership)

Discussion about this post

User's avatar
Guillermou's avatar
Guillermou
2dEdited

THE REAL DIFFERENCE BETWEEN NATURAL SALICYLATES IN VEGETABLES AND ACETYLSALICYLIC ACID (ASPIRIN)--The drawback is that it's more difficult to achieve an effective dose.

1. The Chemical "Key": The Acetyl Group

The main difference is that aspirin has an artificially added acetyl group.

• In Aspirin: This acetyl group acts like a "missile" that irreversibly blocks an enzyme called COX-1. This is why aspirin has such a powerful effect in preventing blood clots (antiplatelet), but it's also why it can damage the stomach lining and cause bleeding.

• In Fruits and Vegetables: Natural salicylates do not have this acetyl group. Because they lack it, they don't aggressively attack COX-1. Therefore, they don't usually cause ulcers or bleeding problems, even if you consume vegetables with high levels of salicylates.

• In Fruits and Vegetables: Natural salicylates do not have this acetyl group. Because they lack it, they don't aggressively attack COX-1. Therefore, they don't usually cause ulcers or bleeding problems, even if you consume vegetables with high levels of salicylates. 2. The Final Destination: Salicylic Acid

When you take aspirin, your body quickly cleaves the acetyl group, leaving salicylic acid in your bloodstream—exactly the same thing you get from eating fruits and vegetables.

• The Vegetable Advantage: You get the benefits of salicylic acid (AMPK activation, c-MYC reduction, miR-34 stimulation) without the stomach-irritating acetyl group.

• Dosage and Consistency: A person with a diet rich in vegetables and spices (such as cumin, paprika, or oregano) can maintain blood levels of salicylic acid similar to someone chronically taking infant aspirin, but in a much safer and more natural way.

3. Bioavailability and Synergy

In fruits and vegetables, salicylate doesn't come alone:

• It's accompanied by polyphenols and fiber, which modulate its absorption.

• Consuming broccoli and mustard seeds allows you to activate the natural sulforaphane and salicylates that work together in liver detoxification pathways, something a synthetic pill cannot replicate.

The effect of plant silicates on platelets is very mild/safe. The effect on the stomach is generally protective. It directly activates AMPK. Aspirin is very strong (risk of bleeding) and irritating (risk of ulcers). Its action occurs after metabolism.

In conclusion: The salicylates in fruits and vegetables are the "smart" and safe option. They allow you to activate cancer defense mechanisms (the AMPK pathway mentioned earlier) consistently and daily without worrying about the gastric toxicity or bleeding that pharmaceutical aspirin can cause in the long term.

Spices are the most potent sources of salicylic acid.

Cumin and turmeric: Contain very high levels.

Paprika and cinnamon: Paprika, in particular, has massive concentrations. 1. Oregano, Thyme, and Rosemary: Dried herbs that you can easily add to your smoothies or meals.

Mustard: Activates sulforaphane, also a significant dose of salicylates.

2. Vegetables (Cruciferous and others)

Broccoli and Cauliflower: Excellent sources that also synergize with sulforaphane.

Cucumber and Zucchini: The zucchini you use in your 5 pm smoothie is a consistent source.

Peppers (especially hot or very red ones): Contain high levels.

Radishes: Ideal to combine with cruciferous vegetables.

3. Fruits (Berries and Forest Fruits)

Fruits with intense colors tend to have a higher content:

Raspberries and Strawberries: They are the queens of salicylic acid in the fruit kingdom.

Blueberries and Blackberries: Highly recommended for their additional antioxidant content. Dates and Raisins: They have a very high concentration, although they should be consumed in moderation due to their glucose level.

Reply
Share
Guillermou's avatar
Guillermou
2d

Great report. It's fascinating how science is rediscovering ancient compounds through the lens of modern molecular biology. The mechanism you describe is indeed astonishingly elegant because it doesn't rely on an external cytotoxic attack, but rather on restoring the cell's metabolic intelligence.

It's a paradigm shift: moving from simply inhibiting inflammation (via COX) to epigenetic and metabolic modulation.

Three steps you mention are so disruptive in preventive oncology:

1. Salicylate as a Metabolic "Trojan Horse"

By activating AMPK, salicylate tricks the cancer cell into believing there's an energy crisis.

• The cancer trap: Tumor cells are addicted to consuming energy for their uncontrolled division.

• The effect: When the fuel sensor (AMPK) is activated, the cell is forced to halt cell building processes (anabolism) and prioritize survival, which abruptly stops the cell division cycle that the c-MYC gene tries to maintain at all costs.

2. The release of NRF2 and the p53 bypass

This is the most revolutionary aspect of the research you cite.

• The p53 problem: Historically, it was thought that if the p53 gene (the "guardian") was mutated or absent, the cell was doomed to become cancerous because it could not activate suppressor microRNAs like miR-34.

• The salicylate solution: By removing c-MYC's block on NRF2, salicylate opens a "back door." NRF2 takes over and activates the defenses (miR-34) without needing p53. This is like having a secondary fire suppression system that activates when the main panel fails.

3. Salicylate vs. Aspirin: The Importance of the Acetyl Group

This article touches on a crucial point: the difference between aspirin (acetylsalicylic acid) and salicylate (salicylic acid).

• Aspirin rapidly breaks down into salicylate in the body.

• The main antitumor effect comes from salicylate and its interaction with AMPK. This opens the door to using forms of salicylates that could be less aggressive to the gastric mucosa than conventional aspirin, since we would not depend exclusively on COX-1 inhibition to obtain the preventive benefit.

• Pathway Summary:

Salicylate→↑AMPK→↓c−MYC→↑NRF2→↑miR−34→Tumor Suppression

This mechanism reinforces the idea that fighting cancer is not just about "killing" cells, but about reprogramming the cellular environment so that the body itself regains control of its growth.

This is a very powerful perspective, especially considering that c-MYC is a target that the pharmaceutical industry has unsuccessfully tried to block with complex drugs for decades, and it turns out that a compound derived from willow bark might hold the key.

“ASCOLT 2025 Protocol”: This is the definitive study on aspirin after colon surgery.

The ASCOLT (Aspirin after completion of standard adjuvant therapy for colorectal cancer) trial is a major international, randomized, double-blind, phase 3 study exploring whether aspirin can improve survival outcomes in patients with resected stage II and III colorectal cancer. Results published in early 2025 indicated that while aspirin was well-tolerated, daily administration did not significantly improve disease-free survival.

“AMPK-MYC Salicylate Axis”: The elegant mechanism you yourself described.

Salicylate (the active metabolite of aspirin) exerts a potent chemopreventive and antitumor effect in colorectal cancer through the regulation of the AMPK-MYC axis. This mechanism acts as a metabolic switch that induces the degradation of the c-MYC oncogene.

“ALASSCA Study”: The one that links aspirin to the PIK3CA gene.

“ALASSCA Study” The ALASCCA (Adjuvant Low Dose Aspirin in Colorectal Cancer) study is a randomized, double-blind clinical trial investigating whether low-dose aspirin (160 mg daily) can reduce the risk of recurrence in patients with colorectal cancer, specifically those with a PIK3CA gene mutation. This adjuvant treatment aims to improve survival by inhibiting tumor-specific metabolic pathways.

https://www.cam.ac.uk/research/news/scientists-discover-how-aspirin-could-prevent-some-cancers-from-spreading (2025)

https://www.mdpi.com/1422-0067/27/3/1288 (2025)

https://www.mdpi.com/2076-3921/14/1/29 (2024)

https://www.nature.com/articles/s41419-023-06226-9 (2023)

https://portal.findresearcher.sdu.dk/en/publications/salicylate-elicited-activation-of-amp-activated-protein-kinase-di/ (2025)

https://www.sciencedirect.com/science/article/abs/pii/S0002961026002114 (2026)

https://www.thelancet.com/journals/langas/article/PIIS2468-1253(2400387-X/abstract (2026)

https://www.bjsacademy.com/bjs-academy/randomized-clinical-trials/aspirin-after-completion-of-standard-adjuvant-therapy-for-colorectal-cancer-ascolt-an-international-multicentre-phase-3-randomised-double-blind-placebo-controlled-trial (2026)

https://www.nccs.com.sg/news/research/conclusion-of-global-multicentre-trial-defines-aspirins-role-in-reducing-colorectal-cancer-recurrence (2025)

https://pubmed.ncbi.nlm.nih.gov/39824200/ (2025)

https://clinicaltrials.gov/study/NCT02647099 (2026)

Reply
Share
8 more comments...

No posts

Ready for more?

© 2026 Dr. Joseph Mercola · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture